ArticleProceedings of the National Academy of Sciences of the United States of America2026
A GTP synthase ribozyme with increased GTP turnover.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
Before the invention of encoded protein translation, early stages of life likely relied on catalytic RNAs (ribozymes). To test how such a system could have functioned, researchers have developed ribozymes that could have provided central functions. The central function of self-replication would have required templated RNA polymerization of nucleotides, which is energetically driven in today's life forms by the use of nucleoside 5'-triphosphates (NTPs). We previously showed that ribozymes can catalyze the formation of guanosine 5'-triphosphate (GTP) from guanosine and the prebiotically plausible polyphosphorylation reagent cyclic trimetaphosphate (cTmp) by generating a guanosine triphosphorylation ribozyme (GTR) using an in vitro selection in emulsion. This ribozyme (GTR1) had a catalytic rate enhancement of about 18,000-fold but a turnover of only about 1.7. Here, we improved this ribozyme by emulsion selection from a doped library of GTR1 that was metabolically coupled to a polymerase ribozyme. High-throughput sequencing and biochemical analysis identified the most efficient variant of GTR1 with 19 mutations, which increased the GTP turnover number to ~13. Biochemical analysis of this GTR1e revealed biphasic reaction kinetics with an apparent overall K
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.